Why the study?
Exaggerated blood pressure variability stresses the cardiovascular system independently of average blood pressure, but its impact on hypertensive target organ damage and cardiovascular events required assessment.
Does high visit-to-visit blood pressure variability increase the risk of cardiovascular events and target organ damage in patients from a hypertension registry?
Does high visit-to-visit blood pressure variability increase the risk of cardiovascular events and target organ damage in patients from a hypertension registry?
Visit-to-visit blood pressure variability is an independent risk factor for target organ damage and cardiovascular events, beyond mean blood pressure values.
Should not yet change practice; leaves open whether reducing visit-to-visit variability independently prevents events beyond mean BP and HMOD.
BACKGROUND: Exaggerated variability of blood pressure (BP) poses additional stress on cardiovascular system independent of BP average value, increasing risk of target organ damage (HMOD) and cardiovascular events. We assessed the impact of visit-to-visit variability (VVV) of BP on development of cardiovascular events and HMOD. METHODS: Standard deviation (SD) and coefficient of variability of mean SBP and DBP were calculated in 3555 patients from the Campania Salute Network registry, with available echocardiogram and more than six visits during follow-up. Values from the first visit were excluded. The impact of VVV of BP on cardiovascular events, and mediation of HMOD were assessed at final visit. RESULTS: Mean number of visits was 11 ± 6 with mean interval between visits of 9.1 ± 3.7 months. Mean visit-to-visit SD during follow-up was 13 ± 5 for systolic and 8 ± 3 mmHg for DBP; coefficients of variability were 9.7 ± 3.5 and of 9.6 ± 3.2, respectively. In multivariable analysis, left ventricular mass at follow-up was correlated with systolic VVV of BP independently of significant effect of age, BMI, mean SBP during follow-up and initial left ventricular mass. Follow-up GFR was inversely associated with systolic and diastolic VVV, independently of significant effect of age, mean glucose and SBP during follow-up, and initial GFR. In Cox regression, high VVV of BP was also associated with increased risk of cardiovascular events (hazard ratio 1.49, 95% confidence interval 1.08-2.06, P = 0.015), independently of significant effect of HMOD. CONCLUSION: VVV is associated with prevalent HMOD and development of cardiovascular events, independently of mean BP value during follow-up and HMOD.
No takes yet. Share an insight, caveat, or question.
Mancusi et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: